Candidiasis, Vulvovaginal Clinical Trial
Official title:
A Randomized Controlled Trial: the Effect of a Medical Grade Honey Formulation (L-Mesitran) on Clinical Symptoms of Recurrent Vulvovaginal Candidiasis
The aim of the study is to investigate the efficacy of Fluconazol versus L-Mesitran in the treatment of patients with recurrent vulvovaginal candidiasis. Vaginal swabs will be analyzed after 1, 6 and 12 months. The study ends after 252 included patients completed the study.
The purpose of this study is to investigate the vaginal culture (positive or negative) after the application of a Medical Grade Honey formulation (L-Mesitran ®) in relation to the current standard of care (Fluconazole) 1 month after starting treatment in patients with RVCC. As a secondary outcome, the effects on symptoms, including redness, irritation, itching, dysuria, dyspareunia and vaginal discharge will be analyzed. In addition, the vaginal culture after 6 months maintenance application and the number of relapses within 12 months will be investigated. Moreover, information about side effects, discomfort, and quality of life will be collected and compared. The study ends after 252 included patients completed the study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02971007 -
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
|
Phase 2 | |
| Completed |
NCT02251093 -
Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis
|
Phase 3 | |
| Completed |
NCT01293643 -
A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)
|
Phase 3 | |
| Not yet recruiting |
NCT04626258 -
Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis
|
Phase 4 | |
| Completed |
NCT02733432 -
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
|
Phase 2 | |
| Completed |
NCT02248506 -
Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis
|
Phase 4 | |
| Completed |
NCT02730494 -
Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation
|
Phase 1 | |
| Completed |
NCT02180828 -
Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis
|
Phase 4 | |
| Recruiting |
NCT04930107 -
Vulvovaginal Candidiasis in Canadian Females
|
Early Phase 1 | |
| Withdrawn |
NCT03167957 -
Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis
|
Phase 2 | |
| Terminated |
NCT02859493 -
Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis
|
N/A | |
| Completed |
NCT01891331 -
A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)
|
Phase 2 | |
| Completed |
NCT02888197 -
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
|
N/A | |
| Completed |
NCT03975569 -
Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis
|
N/A | |
| Recruiting |
NCT05059145 -
A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis
|
Phase 2 | |
| Recruiting |
NCT03075046 -
Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial
|
N/A |